Compounds > acetyl coenzyme a
Page last updated: 2024-08-17

acetyl coenzyme a and Leukemia, Myeloid, Acute

acetyl coenzyme a has been researched along with Leukemia, Myeloid, Acute in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eagle, K; Hoegenauer, KA; Hu, T; Jiang, Y; Kitano, A; Konopleva, MY; Lin, CY; Nakada, D; Shi, X; Wang, T; Young, NL1
Traer, E1
Lee, IS; Lim, HW; Maksimoska, J; Man, N; Marmorstein, R; Meier, J; Newman, JC; Nimer, S; Ott, M; Schröder, S; Shimazu, T; Shirakawa, K; Sorum, AW; Verdin, E; Wang, L1

Other Studies

3 other study(ies) available for acetyl coenzyme a and Leukemia, Myeloid, Acute

ArticleYear
AMP-activated protein kinase links acetyl-CoA homeostasis to BRD4 recruitment in acute myeloid leukemia.
    Blood, 2019, 12-12, Volume: 134, Issue:24

    Topics: Acetyl Coenzyme A; Acetylation; AMP-Activated Protein Kinases; Animals; Cell Cycle Proteins; Cell Line, Tumor; Disease Models, Animal; Gene Expression Regulation, Leukemic; Histones; Homeostasis; Humans; Leukemia, Myeloid, Acute; Mice; Neoplasm Grading; Protein Binding; Transcription Factors; Xenograft Model Antitumor Assays

2019
Reducing acetyl-CoA enhances BET inhibition.
    Blood, 2019, 12-12, Volume: 134, Issue:24

    Topics: Acetyl Coenzyme A; AMP-Activated Protein Kinases; Cell Cycle Proteins; Homeostasis; Humans; Kinetics; Leukemia, Myeloid, Acute; Nuclear Proteins; Transcription Factors

2019
Salicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activity.
    eLife, 2016, 05-31, Volume: 5

    Topics: Acetyl Coenzyme A; Acetylation; Animals; Antineoplastic Agents; Binding, Competitive; Catalytic Domain; Cell Line, Tumor; Core Binding Factor Alpha 2 Subunit; Diflunisal; Enzyme Inhibitors; Gene Expression Regulation, Leukemic; HEK293 Cells; Humans; Leukemia, Myeloid, Acute; Leukocytes; Mice; Mice, SCID; Oncogene Proteins, Fusion; p300-CBP Transcription Factors; Protein Binding; RUNX1 Translocation Partner 1 Protein; Salicylic Acid; Signal Transduction; Structure-Activity Relationship; Xenograft Model Antitumor Assays

2016